J. Ward Kennedy, MD
The general impression in the United States is that thrombolytic therapy for acute myocardial infarction is underutilized. Grines and DeMaria (1), as well as others (2-4), have recently estimated that only about 10% of eligible patients with acute myocardial infarction receive thrombolytic therapy. Because thrombolytic therapy is now accepted as the best initial treatment for many patients with acute myocardial infarction, it is important to understand the reasons for its underutilization and find ways to correct the situation.
In this issue of Annals, Muller and Topol (5) review the current selection and exclusion criteria for the use of thrombolytic therapy
Kennedy JW. Expanding the Use of Thrombolytic Therapy for Acute Myocardial Infarction. Ann Intern Med. ;113:907–908. doi: 10.7326/0003-4819-113-12-907
Download citation file:
Published: Ann Intern Med. 1990;113(12):907-908.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use